| Subject | Predicate | Object | Context |
|---|---|---|---|
| http://identifiers.org/pubm... | rdf:type | biopax3:PublicationXref | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Borggrefe M | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Hoffmann R | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Kiel G | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Ortlepp JR | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Mevissen V | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:author | Hanrath P | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:db | PubMed | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:id | 12065207 | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:source | Eur J Pharmacol 445(1-2);151-2 | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:title | Variants of the CYP11B2 gene predict response to therapy with candesartan. | lld:biopax3 |
| http://identifiers.org/pubm... | biopax3:year | 2002 | lld:biopax3 |
| http://biocyc.org/biopax/bi... | biopax3:xref | http://identifiers.org/pubm... | lld:biopax3 |